All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10370047" target="_blank" >RIV/00216208:11110/17:10370047 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/17:10370047 RIV/00064203:_____/17:10370047 RIV/00064165:_____/17:10370047

  • Result on the web

    <a href="http://dx.doi.org/10.1159/000477962" target="_blank" >http://dx.doi.org/10.1159/000477962</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1159/000477962" target="_blank" >10.1159/000477962</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors

  • Original language description

    Background: In adults, infliximab (IFX) levels correlate with disease activity, and antibodies to IFX (ATIs) predict treatment failure. We aimed to determine the association of IFX levels and ATIs with disease activity in a paediatric population. We prospectively collected blood, stool, and clinical data from 65 patients (age 10.5-15.1 years) with Crohn&apos;s disease (CD) before IFX administration, and measured IFX trough levels, ATIs, and faecal calprotectin levels (CPT). Samples were collected during maintenance therapy. We used multivariate analysis to identify the predictors of IFX levels. Summary: Lower levels of IFX were associated with ATIs positivity (OR 0.027, 95% CI 0.009-0.077). Higher C-reactive protein (CRP) level, erythrocyte sedimentation rate, and CPT levels were found in patients with lower IFX levels. The optimal combination of sensitivity (0.5) and specificity (0.74) for disease activity was calculated for IFX levels &gt;=1.1 µg/mL using CRP level &lt;5 mg/L as a marker of laboratory remission. In a model that used CPT &lt;=100 µg/g as the definition of remission, the optimal IFX trough level was 3.5 µg/mL. No independent association between remission and ATIs was found in our study population. However, we found an independentz association between IFX levels and serum albumin levels (OR 1.364, 95% CI 1.169-1.593), p &lt; 0.001. Key Messages: The paediatric population was similar to adult populations in terms of the association between IFX and ATIs as well as between IFX and disease activity,

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30219 - Gastroenterology and hepatology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Digestive Diseases

  • ISSN

    0257-2753

  • e-ISSN

  • Volume of the periodical

    36

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    9

  • Pages from-to

    40-48

  • UT code for WoS article

    000415245000006

  • EID of the result in the Scopus database

    2-s2.0-85027690993